Twin Tree Management
BMRN icon

Twin Tree Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Twin Tree Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,703
Closed -$612K – 1473
2025
Q2 		$588K Sell
10,703
-40,577
-79% -$2.39M ﹤0.01% 1426
2025
Q1 		$3.62M Buy
+51,280
New +$3.45M 0.01% 998
2024
Q3 		– Sell
-34,022
Closed -$2.84M – 1511
2024
Q2 		$2.8M Buy
34,022
+29,986
+743% +$2.5M 0.01% 891
2024
Q1 		$353K Sell
4,036
-55,649
-93% -$4.98M ﹤0.01% 1124
2023
Q4 		$5.75M Buy
59,685
+12,932
+28% +$1.14M 0.01% 836
2023
Q3 		$4.14M Buy
+46,753
New +$4.16M 0.01% 730
2023
Q1 		– Sell
-67,022
Closed -$6.95M – 1294
2022
Q4 		$6.94M Buy
67,022
+35,714
+114% +$3.35M 0.02% 669
2022
Q3 		$2.65M Buy
31,308
+11,540
+58% +$1.03M 0.01% 896
2022
Q2 		$1.64M Sell
19,768
-6,114
-24% -$487K ﹤0.01% 1119
2022
Q1 		$2M Sell
25,882
-9,373
-27% -$784K ﹤0.01% 1162
2021
Q4 		$3.12M Buy
+35,255
New +$2.91M 0.01% 987
2021
Q3 		– Sell
-11,701
Closed -$923K – 1565
2021
Q2 		$976K Buy
11,701
+5,507
+89% +$437K ﹤0.01% 1023
2021
Q1 		$468K Sell
6,194
-35,784
-85% -$2.92M ﹤0.01% 1070
2020
Q4 		$3.68M Buy
41,978
+23,814
+131% +$1.89M 0.01% 706
2020
Q3 		$1.38M Sell
18,164
-34,830
-66% -$3.52M 0.01% 840
2020
Q2 		$6.54M Buy
+52,994
New +$5.27M 0.03% 578
2019
Q2 		– Sell
-401
Closed -$36K – 1246
2019
Q1 		$36K Buy
+401
New +$37.2K ﹤0.01% 1126
2018
Q2 		– Sell
-534
Closed -$43K – 1146
2018
Q1 		$43K Buy
+534
New +$45.8K ﹤0.01% 1013

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Twin Tree Management's BMRN Position: Q3 2025 in Review

Twin Tree Management sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2025, closing a stake of 10,703 shares — an estimated $612K sold.

Twin Tree Management first reported a position in BMRN in Q1 2018 and held it in 18 quarters. The position peaked at $6.94M in Q4 2022. 576 funds tracked by Wall St. Rank hold BMRN as of Q3 2025.

  • Twin Tree Management reported no remaining BioMarin Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Twin Tree Management sold 10,703 BioMarin Pharmaceuticals shares in Q3 2025, an estimated $612K.
  • Twin Tree Management first reported a position in BioMarin Pharmaceuticals in Q1 2018 and held it in 18 quarters.
  • Twin Tree Management's BioMarin Pharmaceuticals position peaked at $6.94M in Q4 2022.
  • 576 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2025.

Based on Twin Tree Management's 13F filing for Q3 2025, filed 13 Nov 2025.